Rosa A. Maldonado to Antiprotozoal Agents
This is a "connection" page, showing publications Rosa A. Maldonado has written about Antiprotozoal Agents.
Connection Strength
2.486
-
Rodriguez F, John SF, Iniguez E, Montalvo S, Michael K, White L, Liang D, Olaleye OA, Maldonado RA. In Vitro and In Vivo Characterization of Potent Antileishmanial Methionine Aminopeptidase 1 Inhibitors. Antimicrob Agents Chemother. 2020 05 21; 64(6).
Score: 0.716
-
Rodriguez F, Iniguez E, Pena Contreras G, Ahmed H, Costa TEMM, Skouta R, Maldonado RA. Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by Leishmania major. Molecules. 2018 07 04; 23(7).
Score: 0.628
-
Herrera LJ, Brand S, Santos A, Nohara LL, Harrison J, Norcross NR, Thompson S, Smith V, Lema C, Varela-Ramirez A, Gilbert IH, Almeida IC, Maldonado RA. Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi. PLoS Negl Trop Dis. 2016 Apr; 10(4):e0004540.
Score: 0.540
-
Vasquez MA, Iniguez E, Das U, Beverley SM, Herrera LJ, Dimmock JR, Maldonado RA. Evaluation of a,?-unsaturated ketones as antileishmanial agents. Antimicrob Agents Chemother. 2015; 59(6):3598-601.
Score: 0.500
-
Mart?nez A, Carreon T, Iniguez E, Anzellotti A, S?nchez A, Tyan M, Sattler A, Herrera L, Maldonado RA, S?nchez-Delgado RA. Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells. J Med Chem. 2012 Apr 26; 55(8):3867-77.
Score: 0.102